At Manningham Medical Centre, you can find all the data about Thromboprophylaxis In Acutely Ill Medical Patients. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Rivaroxaban for Thromboprophylaxis in Acutely Ill …

    https://www.nejm.org/doi/full/10.1056/NEJMoa1111096
    In acutely ill medical patients, rivaroxaban was noninferior to enoxaparin for standard-duration thromboprophylaxis. Extended-duration rivaroxaban reduced the risk of venous thromboembolism. Rivaroxaban was associated with an increased risk of bleeding. (Funded by Bayer HealthCare Pharmaceuticals and … See more

Apixaban versus Enoxaparin for Thromboprophylaxis in …

    https://www.nejm.org/doi/full/10.1056/NEJMoa1110899
    One study (the Extended Prophylaxis for Venous Thromboembolism in Acutely Ill Medical Patients with Prolonged Immobilization trial …

Thromboprophylaxis Strategies in Acute Medically Ill Patients

    https://link.springer.com/article/10.1007/s40138-019-00191-4
    Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness (MARINER Trial) The MARINER trial was a randomized, double-blind, placebo-controlled, multinational clinical trial that randomized patients at hospital discharge in a 1:1 ratio to rivaroxaban or placebo for 45 days [ 11 •].

Rivaroxaban for thromboprophylaxis in acutely ill medical …

    https://pubmed.ncbi.nlm.nih.gov/23388003/
    Methods: We randomly assigned patients 40 years of age or older who were hospitalized for an acute medical illness to receive subcutaneous enoxaparin, 40 mg …

Extended Thromboprophylaxis with Betrixaban in Acutely …

    https://www.nejm.org/doi/10.1056/NEJMoa1601747
    Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once daily) for 10±4 …

Thrombo-prophylaxis in acutely ill medical and critically ill …

    https://pubmed.ncbi.nlm.nih.gov/24987238/
    Thrombo-prophylaxis has been shown to reduce the incidence of pulmonary embolism (PE) and mortality in surgical patients. The purpose of this review is to find out the evidence …

Extended Thromboprophylaxis with Betrixaban in Acutely …

    https://pubmed.ncbi.nlm.nih.gov/27232649/
    Methods: Patients who were hospitalized for acute medical illnesses were randomly assigned to receive subcutaneous enoxaparin (at a dose of 40 mg once daily) …

Extended-duration rivaroxaban thromboprophylaxis in …

    https://pubmed.ncbi.nlm.nih.gov/21359646/
    Patients with acute medical illnesses are at increased risk of venous thromboembolism (VTE), a significant cause of morbidity and mortality. Thromboprophylaxis is …

[Pharmacological Thromboprophylaxis in Acutely Ill Hospitalized Medical ...

    https://pubmed.ncbi.nlm.nih.gov/33895004/
    Abstract. Venous thromboembolic events (VTE) occur in approximately 50% of cases during or following hospitalization; VTE are a major cause of morbidity and mortality. Thromboprophylaxis for 6 to 14 days with heparins or fondaparinux has been demonstrated to be effective in VTE prevention in patients hospitalized for acute medical illnesses and …

Extended-duration thromboprophylaxis in acutely ill …

    https://pubmed.ncbi.nlm.nih.gov/16786230/
    Conclusions: The EXCLAIM study is designed to show the efficacy and safety of extended-duration thromboprophylaxis using enoxaparin in acutely ill medical …



Need more information about Thromboprophylaxis In Acutely Ill Medical Patients?

At Manningham Medical Centre, we collected data on more than just Thromboprophylaxis In Acutely Ill Medical Patients. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.